Eptinezumab (Anti-CALCA / CGRP)

Synonyms:

Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.

Eptinezumab (Anti-CALCA / CGRP)

Purity & Quality Control

≥99

Choose Selective CGRP Receptor Inhibitors

Biological Activity

Description Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.

Product Details

CAS No. 1644539-04-7
Molecular Weight 143.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Eptinezumab (Anti-CALCA / CGRP) | Eptinezumab (Anti-CALCA / CGRP) supplier | purchase Eptinezumab (Anti-CALCA / CGRP) | Eptinezumab (Anti-CALCA / CGRP) cost | Eptinezumab (Anti-CALCA / CGRP) manufacturer | order Eptinezumab (Anti-CALCA / CGRP) | Eptinezumab (Anti-CALCA / CGRP) distributor